David Westenberg
Stock Analyst at Piper Sandler
(3.56)
# 819
Out of 4,843 analysts
176
Total ratings
46.6%
Success rate
5.92%
Average return
Main Sectors:
Stocks Rated by David Westenberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Maintains: Neutral | $55 → $70 | $55.18 | +26.86% | 4 | May 15, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Neutral | $2 → $1.25 | $0.96 | +29.71% | 8 | May 15, 2025 | |
| NTRA Natera | Maintains: Overweight | $205 → $210 | $157.73 | +33.14% | 15 | May 15, 2025 | |
| ILMN Illumina | Maintains: Overweight | $190 → $185 | $82.24 | +124.95% | 16 | May 15, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $205 → $210 | $168.63 | +24.53% | 14 | May 12, 2025 | |
| LH Labcorp Holdings | Maintains: Neutral | $260 → $280 | $248.97 | +12.46% | 4 | May 6, 2025 | |
| NEO NeoGenomics | Maintains: Overweight | $18 → $12 | $7.27 | +65.06% | 9 | May 6, 2025 | |
| GH Guardant Health | Maintains: Overweight | $50 → $60 | $40.62 | +47.71% | 9 | May 6, 2025 | |
| FLGT Fulgent Genetics | Maintains: Neutral | $16 → $23 | $20.72 | +11.00% | 8 | May 6, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Overweight | $11 → $13 | $9.52 | +36.55% | 13 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $200 | $173.34 | +15.38% | 7 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.4 → $5 | $5.86 | -14.68% | 12 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.4 → $1.65 | $1.25 | +32.00% | 8 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $12 | $13.44 | -10.71% | 9 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8.5 → $8 | $2.77 | +188.81% | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $70 | $56.28 | +24.38% | 10 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $435 → $510 | $513.36 | -0.65% | 10 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.5 → $3 | $3.32 | -9.64% | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $9.53 | - | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $30.67 | - | 2 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $47.19 | - | 1 | Nov 21, 2017 |
Tempus AI
May 15, 2025
Maintains: Neutral
Price Target: $55 → $70
Current: $55.18
Upside: +26.86%
Pacific Biosciences of California
May 15, 2025
Maintains: Neutral
Price Target: $2 → $1.25
Current: $0.96
Upside: +29.71%
Natera
May 15, 2025
Maintains: Overweight
Price Target: $205 → $210
Current: $157.73
Upside: +33.14%
Illumina
May 15, 2025
Maintains: Overweight
Price Target: $190 → $185
Current: $82.24
Upside: +124.95%
Zoetis
May 12, 2025
Maintains: Overweight
Price Target: $205 → $210
Current: $168.63
Upside: +24.53%
Labcorp Holdings
May 6, 2025
Maintains: Neutral
Price Target: $260 → $280
Current: $248.97
Upside: +12.46%
NeoGenomics
May 6, 2025
Maintains: Overweight
Price Target: $18 → $12
Current: $7.27
Upside: +65.06%
Guardant Health
May 6, 2025
Maintains: Overweight
Price Target: $50 → $60
Current: $40.62
Upside: +47.71%
Fulgent Genetics
May 6, 2025
Maintains: Neutral
Price Target: $16 → $23
Current: $20.72
Upside: +11.00%
Adaptive Biotechnologies
May 6, 2025
Maintains: Overweight
Price Target: $11 → $13
Current: $9.52
Upside: +36.55%
Apr 28, 2025
Maintains: Neutral
Price Target: $180 → $200
Current: $173.34
Upside: +15.38%
Apr 22, 2025
Maintains: Neutral
Price Target: $6.4 → $5
Current: $5.86
Upside: -14.68%
Apr 14, 2025
Maintains: Neutral
Price Target: $2.4 → $1.65
Current: $1.25
Upside: +32.00%
Mar 6, 2025
Maintains: Neutral
Price Target: $16 → $12
Current: $13.44
Upside: -10.71%
Mar 4, 2025
Maintains: Overweight
Price Target: $8.5 → $8
Current: $2.77
Upside: +188.81%
Feb 26, 2025
Maintains: Overweight
Price Target: $75 → $70
Current: $56.28
Upside: +24.38%
Feb 10, 2025
Maintains: Neutral
Price Target: $435 → $510
Current: $513.36
Upside: -0.65%
Nov 13, 2023
Maintains: Neutral
Price Target: $3.5 → $3
Current: $3.32
Upside: -9.64%
Mar 5, 2020
Initiates: Buy
Price Target: n/a
Current: $9.53
Upside: -
Jan 4, 2018
Upgrades: Buy
Price Target: n/a
Current: $30.67
Upside: -
Nov 21, 2017
Initiates: Neutral
Price Target: n/a
Current: $47.19
Upside: -